Cannabis use is associated with an increased risk for adverse cardiovascular events, including myocardial infarction ...

Type 1 diabetes was associated with less myocardial infarction, percutaneous coronary intervention, stroke, and limb ischemia than type 2.

Products must note that they can increase blood pressure, but boxed warnings about adverse cardiovascular events can be removed, the FDA announced.

The following is a summary of “Continuous quality improvement for prehospital STEMI improved triage rates and achievement of ...

Too many people still miss heart trouble Is your heart healthy? In a 2015 study published in JAMA, eight out of 10 men and women with scarring on their heart muscle—evidence of a previous heart attack ...

Out-of-hospital cardiac arrest (OHCA) in people experiencing a heart attack is a time-dependent medical emergency requiring ...

In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

In patients with acute heart failure, it is unclear how body mass index affects clinical outcomes following acute myocardial infarction.

Strong results to date of Vafseo U.S. launch; expect Vafseo Q1 2025 net product revenues of approximately $10-$11 millionCash resources and cash ...

Composite of coronary heart disease death and non-fatal myocardial infarction was less frequent in the CCTA group compared to ...

After 2 positive trials, low-dose colchicine’ got the FDA nod for CV reduction but then the CLEAR SYNERGY trial found no ...